News Release: July 24, 2025
AIBA (2,2’-Azobis(2-amidinopropane) Dihydrochloride) Price, Production, Latest News and Developments in 2025
AIBA (2,2’-Azobis(2-amidinopropane) Dihydrochloride) price trend and production news
AIBA (2,2’-Azobis(2-amidinopropane) Dihydrochloride) Price Trend in Past Five Years and Factors Impacting Price Movements (2019–2024)
Over the last five years, the AIBA (2,2’-Azobis(2-amidinopropane) Dihydrochloride) price trend has reflected significant volatility, primarily driven by fluctuations in raw material costs, manufacturing disruptions, logistics bottlenecks, and regulatory shifts.
In 2019, the average AIBA price stood at around $4,200/MT. Prices remained relatively stable during this period as raw materials such as ammonium persulfate and acrylonitrile were readily available. However, the onset of the COVID-19 pandemic in early 2020 led to disruptions in the supply chain, causing a slight price surge to $4,500/MT in Q2 2020 due to shortages in precursor chemicals and lower production volumes.
By 2021, with global supply chains starting to stabilize, AIBA prices began to normalize, dropping to approximately $4,350/MT in Q1. However, as the year progressed, rising energy prices and increased freight costs pushed the average AIBA price upward again, closing the year at $4,800/MT.
The year 2022 saw continued inflationary pressure and stricter environmental regulations in key production hubs like China, where some AIBA manufacturing facilities were temporarily shut for inspections. Consequently, prices climbed steeply, peaking at $5,200/MT by Q3 2022. These regulatory factors and transportation hurdles significantly impacted AIBA production and distribution schedules.
In 2023, a global focus on specialty polymer and biomedical research further boosted the AIBA (2,2’-Azobis(2-amidinopropane) Dihydrochloride) sales volume, increasing demand and thereby supporting higher price points. Prices hovered around $5,300/MT through most of the year.
Heading into 2024, the market experienced a mild correction. Improved production efficiency, higher operating capacity in Southeast Asia, and greater availability of raw materials led to moderate easing in prices, bringing the average AIBA (2,2’-Azobis(2-amidinopropane) Dihydrochloride) price down to $5,000/MT.
Overall, key influencing factors over the five-year period included:
- Fluctuating input costs (e.g., ammonium salts)
- Pandemic-induced supply chain disruptions
- Environmental regulations and shutdowns
- Freight rate spikes
- R&D-driven demand in biotechnology and pharmaceuticals
- Regional capacity expansions and supply-demand imbalances
AIBA (2,2’-Azobis(2-amidinopropane) Dihydrochloride) Price Trend Quarterly Update (2025 Estimated Prices in $/MT)
Based on recent developments and estimated Q1 and Q2 trends, the following is the projected quarterly AIBA price trend for 2025:
- Q1 2025: $5,050/MT – Minor increase driven by post-holiday demand recovery in Asia.
- Q2 2025: $5,180/MT – A modest spike reflecting increased demand in pharmaceutical sectors for water-soluble azo initiators.
- Q3 2025: $5,250/MT – Anticipated peak due to seasonal industrial uptick and short-term raw material tightness.
- Q4 2025: $5,100/MT – Slight decrease as supply improves from added production capacity in South Korea and Malaysia.
These fluctuations are in line with typical seasonal cycles and the influence of international trade activity. AIBA (2,2’-Azobis(2-amidinopropane) Dihydrochloride) production facilities are currently operating at higher efficiency due to technological upgrades introduced in 2024, helping balance the price against rising demand.
Global AIBA (2,2’-Azobis(2-amidinopropane) Dihydrochloride) Import-Export Business Overview (2025)
The global AIBA (2,2’-Azobis(2-amidinopropane) Dihydrochloride) trade landscape is experiencing dynamic shifts in 2025, as countries reevaluate supply chain dependencies and strategic reserves of polymerization initiators. AIBA is a water-soluble azo compound mainly used in biomedical research, radical polymerizations, and personal care product formulations. Its growing demand is driven by its role in clean polymer chemistry, especially in aqueous environments.
China continues to dominate the AIBA export market in 2025, accounting for nearly 48% of global exports. Despite tightening environmental regulations in the previous years, Chinese producers have scaled up capacities with upgraded emissions management systems. New export hubs in Jiangsu and Zhejiang provinces have emerged, supported by proximity to both raw materials and coastal logistics.
India is rapidly expanding its presence in the global AIBA market. With the Indian government promoting specialty chemical manufacturing under “Make in India,” the country has seen a 22% year-over-year rise in AIBA (2,2’-Azobis(2-amidinopropane) Dihydrochloride) production in FY2024-25. Indian companies are increasingly exporting to the Middle East, South Korea, and Germany.
Meanwhile, the United States remains a key importer due to its strong pharmaceutical and academic research base. However, domestic production has also shown signs of revival. Several biotech-focused specialty chemical companies in the U.S. have announced plans to invest in small-batch, high-purity AIBA manufacturing units, aiming to reduce reliance on Asian imports.
Germany and France represent the largest consumers within the EU, where AIBA is widely used in polymer chemistry labs and for manufacturing specialty hydrogels. Europe has seen increased imports from India and Taiwan as firms diversify their sources amidst concerns over geopolitical risks in East Asia.
Japan and South Korea are focused on high-purity AIBA applications in electronics and medical-grade materials. Japan’s imports from China have decreased by 15% in the first half of 2025, replaced by contracts with Indian and Vietnamese suppliers. The push towards localizing strategic chemical production has led to increased R&D collaboration and new pilot plants in Osaka and Busan.
Latin America is emerging as a moderate but growing consumer base, led by Brazil and Mexico. These markets are seeing higher imports driven by the expansion of water treatment and personal care industries. However, challenges around port logistics and regulatory compliance continue to affect delivery timelines.
Africa, though still a nascent market for AIBA, is showing early signs of industrial uptake. South African research institutes and cosmetic manufacturers have begun importing small volumes of AIBA, supported by joint ventures with Asian firms.
In terms of export value, the average selling price per ton in Q2 2025 stands as follows:
- China: $4,900/MT (FOB)
- India: $5,100/MT (FOB)
- Taiwan: $5,250/MT (FOB)
- Germany: $5,600/MT (CIF)
- USA: $5,700/MT (CIF)
The AIBA (2,2’-Azobis(2-amidinopropane) Dihydrochloride) sales volume is expected to rise by 8% globally in 2025, with Asia-Pacific accounting for over 55% of total shipments. This growth is primarily being fueled by rising downstream applications in cosmetics, water purification, and biomedical research.
Furthermore, the AIBA (2,2’-Azobis(2-amidinopropane) Dihydrochloride) news in Q2 2025 includes several notable developments:
- A South Korean firm announced the successful synthesis of a high-efficiency AIBA variant with lower decomposition temperature, targeting biomedical applications.
- A U.S.-based chemical company secured a long-term supply agreement with a Chinese manufacturer for AIBA supply at fixed pricing through 2026.
- India’s leading fine chemical producer reported a 16% increase in quarterly AIBA production capacity after commissioning a new reactor unit in Gujarat.
- German regulatory authorities issued new purity guidelines for AIBA used in pharmaceuticals, prompting European importers to seek higher-grade material sources.
As these developments continue to reshape the industry, stakeholders are monitoring both geopolitical and economic indicators to adjust sourcing strategies and pricing models.
For more details and market insights, request a sample from
https://datavagyanik.com/reports/aiba-22-azobis2-amidinopropane-dihydrochloride-market-size-production-sales-average-product-price-market-share-import-vs-export/
AIBA (2,2’-Azobis(2-amidinopropane) Dihydrochloride) Production Trends by Geography (700 words)
The production landscape of AIBA (2,2’-Azobis(2-amidinopropane) Dihydrochloride) has undergone considerable transformation in recent years, influenced by supply chain optimization, regional policy shifts, and rising demand from specialized industries. AIBA, a water-soluble azo compound, is primarily used as a free radical initiator in polymerization processes and biomedical research. In 2025, the global production landscape is largely dominated by Asia-Pacific, followed by Europe and North America.
Asia-Pacific
Asia-Pacific continues to lead the global AIBA production owing to a combination of factors including lower production costs, abundant availability of precursors, and strong downstream demand. China remains the largest single producer of AIBA, accounting for over 45% of global output in 2025. Major chemical manufacturing clusters in Jiangsu, Shandong, and Zhejiang are home to large-scale facilities with integrated supply chains that facilitate economies of scale. Over the past year, several Chinese companies upgraded their facilities to meet international environmental and quality standards, further boosting output and competitiveness.
India is rapidly growing as a secondary production hub. Supportive government policies, investments under the Production Linked Incentive (PLI) scheme, and growing domestic demand have positioned India as a rising contributor in global AIBA production. Indian manufacturers are increasing their export focus, targeting Europe, Southeast Asia, and Latin America. Facilities in Gujarat and Maharashtra have expanded in 2024–25, increasing annual production capacity by more than 20%.
South Korea and Japan, while not leading in volume, are significant producers of high-purity AIBA for niche applications, especially in electronics, cosmetics, and medical research. Their facilities emphasize product purity, quality assurance, and compliance with pharmaceutical-grade specifications.
Europe
Europe plays a key role in the specialty chemicals sector and maintains a notable footprint in AIBA production, especially in Germany and France. European producers focus on producing AIBA with high purity for biotech and pharmaceutical applications. Germany has seen stable production levels in 2025, supported by strong demand from academic institutions and private R&D labs. France, meanwhile, is strengthening its production base through strategic collaborations with Asian manufacturers and joint R&D ventures.
However, higher production costs, stringent regulatory frameworks, and labor constraints continue to limit large-scale manufacturing expansion within the EU. European production is often centered on specialty batches, meeting highly specific industrial or regulatory needs.
North America
In North America, the United States is investing in rebuilding its specialty chemical manufacturing base. While most AIBA consumed in the U.S. is still imported, 2025 marks a shift toward domestic production with the commissioning of several mid-sized facilities focused on biotechnology and medical-grade chemical production. These facilities cater to customized, small-batch requirements of local pharmaceutical and academic clients.
Canada, while having a limited role in actual production, serves as a logistical and distribution hub for North America-bound shipments, often handling materials imported from Asia and Europe.
Middle East and Africa
AIBA production in the Middle East is still in its early stages, with small-scale synthesis being carried out for research purposes and regional industrial needs. However, countries like the UAE and Saudi Arabia are exploring potential investments into specialty chemicals as part of economic diversification efforts. Africa currently lacks domestic AIBA production, with all demand met via imports, primarily from Asia.
Latin America
Latin America’s AIBA production is minimal but growing. Brazil has initiated pilot-scale manufacturing units supported by collaborations with Asian chemical suppliers. These efforts aim to reduce reliance on imports and support local demand from the water treatment and personal care sectors.
In summary, Asia-Pacific remains the dominant producer of AIBA, led by China and followed by India and Japan. Europe maintains strong capabilities in specialized, high-purity production, while North America is gradually expanding its domestic manufacturing base. Emerging regions like the Middle East and Latin America are taking early steps toward building their own production infrastructure in the coming years.
AIBA (2,2’-Azobis(2-amidinopropane) Dihydrochloride) Market Segmentation
Market Segmentation Points:
- By Application
- By Purity Level
- By End-Use Industry
- By Geography
- By Distribution Channel
1. By Application
The AIBA market is segmented based on applications into polymerization initiators, biomedical research, cosmetics formulation, water treatment, and others. Among these, polymerization initiators hold the largest share in 2025 due to AIBA’s effectiveness in initiating free radical polymerizations, particularly in aqueous systems. This is followed by biomedical research applications, where AIBA is used as a source of free radicals in DNA damage studies and cell signaling experiments.
Cosmetic applications are seeing rapid growth as AIBA is used in the production of hydrogels and skin-safe polymers. Water treatment applications also contribute steadily, especially in developing markets where non-toxic polymer additives are in increasing demand.
2. By Purity Level
AIBA is segmented into standard grade and high-purity grade. The standard grade is widely used in industrial polymerization, where minor impurities are tolerable. High-purity AIBA, on the other hand, is required in sensitive applications such as pharmaceuticals, medical diagnostics, and cosmetics. In 2025, demand for high-purity AIBA is growing faster due to increasing regulatory scrutiny and the expansion of biomedical R&D across the globe.
3. By End-Use Industry
The primary industries using AIBA include the chemical manufacturing sector, biotechnology and life sciences, cosmetics and personal care, and academic and research institutions.
Chemical manufacturers utilize AIBA extensively in water-soluble polymer production. In biotechnology, AIBA is valued for generating controlled radical environments for cellular studies. The cosmetics sector is rapidly adopting AIBA for formulations requiring low toxicity and high solubility. Research institutions use AIBA in both educational settings and advanced scientific exploration, contributing to the diversity of demand.
4. By Geography
Geographically, the market is segmented into Asia-Pacific, North America, Europe, Latin America, and Middle East & Africa.
Asia-Pacific dominates due to a concentration of manufacturers and end users. North America is showing strong growth due to increased investments in biotechnology. Europe remains consistent with high-quality demand, while Latin America and the Middle East are emerging markets.
5. By Distribution Channel
Distribution of AIBA occurs through direct sales, international chemical distributors, and e-commerce-based specialty chemical platforms. Direct sales dominate in large-volume markets like China and India. International distributors are preferred for specialty applications and pharma-grade chemicals in North America and Europe.
Detailed Analysis of Leading Segments
The largest and fastest-growing segment by application in 2025 is polymerization initiators. This is primarily due to its essential role in the synthesis of polyacrylamide, polyacrylic acid, and other water-based polymers. As water treatment, cosmetics, and coating industries grow, the demand for these polymers and hence AIBA is expected to remain strong. The polymerization segment alone accounted for nearly 60% of total AIBA consumption in 2024, and this share is projected to increase further.
Biomedical research is another significant and high-margin segment. The use of AIBA in cell biology and drug delivery research has opened avenues for higher-purity production. Growth in this segment is largely concentrated in the U.S., Japan, and Germany, where cutting-edge medical research continues to demand quality reagents.
Cosmetic applications, although smaller in market share, are showing a rapid rise. AIBA’s safe solubility in water and compatibility with sensitive ingredients make it ideal for personal care formulations, gels, and bioactive masks.